{
    "clinical_study": {
        "@rank": "65275", 
        "acronym": "FUSCIA", 
        "arm_group": [
            {
                "arm_group_label": "SAR339658", 
                "arm_group_type": "Experimental", 
                "description": "Dose regimen every 2 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo every 2 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To assess the efficacy of SAR339658\n\n      Secondary Objective:\n\n      To assess the safety of SAR339658"
        }, 
        "brief_title": "Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ulcerative Colitis", 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "The total duration of study period is 18 weeks, broken down as follows:  - 4 weeks for\n      screening - 8 weeks for treatment - 6 weeks for the post treatment safety follow-up A\n      post-study long term safety follow-up will be performed in the form of a phone interview at\n      3, 6, 12, 18 and 24 months from the last administration of the study medication.  After\n      completion of the 8-week treatment phase of this study, patients may be eligible to enter a\n      long term safety study (LTS12593) for active treatment with SAR339658."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria: o Male or Female \u226518  and \u226470 years old o History of active ulcerative\n        colitis of at least 3 months duration o Active UC should be confirmed by colonoscopy or\n        flexible sigmoidoscopy during the screening period within 7 days prior to randomization.\n        o Moderate to severe ulcerative colitis at time of screening, confirmed by Mayo score \u22656\n        to 12 and endoscopy subscore of \u22652 despite treatment with immunosuppressants and/or\n        anti-TNFs:     o Immunosuppressants: Patient must be on concurrent treatment with or have\n        had an inadequate response to (did not respond to or lost response to) or be intolerant to\n        immunosuppressants such as azathioprine, 6-mercaptopurine, or methotrexate.     AND/OR\n        o TNF-alpha antagonists: Patient must have had an inadequate response or lost response or\n        be intolerant to TNF-alpha antagonists  o Fecal calprotectin \u2265200mg/kg o Patients on\n        corticosteroids must be on a stable dose \u22652 weeks prior to screening o Patients on\n        azathioprine, 6- mercaptopurine or methotrexate must be on treatment for at least 12 weeks\n        prior to screening; and on a stable dose \u22654 weeks prior to screening o Patients on oral\n        5-aminosalicylates, mesalamine or sulfasalazine must be on a stable dose for \u22654 weeks\n        prior to screening o Patients na\u00efve to anti-TNF alpha or non responder (primary or\n        secondary) or intolerant to anti-TNF alpha  o Signed written informed consent  Exclusion\n        criteria: o Patients with Crohn's Disease (CD) o Diagnosis of indeterminate colitis o\n        Patients with stool sample positive for ova, parasites, or positive culture for aerobic\n        pathogens including: Aeromonas, Plesiomonas, Shigella, Yersinia, Campylobacter and E. Coli\n        spp. or positive for Clostridium difficile B toxin in stools.   o Patients with prior\n        colectomy or anticipated colectomy during their participation in the study o Presence of\n        ileal pouch or ostomy o Fulminant disease or toxic megacolon o Colonic dysplasia except\n        for adenoma o Total Parenteral Nutrition (TPN) o Cyclosporine, mycophenolate mofetil,\n        sirolimus (rapamycin), thalidomide or tacrolimus within 2 months prior to screening o\n        Previous exposure to natalizumab (Tysabri\u00ae) or vedolizumab o Antidiarrheals within 2 weeks\n        prior to screening  o Prednisone >40 mg/day (or equivalent) o Budesonide >9 mg/day o\n        Received intravenous corticosteroids within 2 weeks prior to screening or during screening\n        o Rectally administered topical 5-aminosalicylate or corticosteroids within 4 weeks prior\n        to screening o Received therapeutic enema or suppository, other than required for\n        colonoscopy or flexible sigmoidoscopy within 4 weeks prior to screening or during\n        screening o Antibiotics for UC or gastrointestinal infection within 4 weeks prior to\n        screening  o Patient who has previously participated in any clinical trial of GBR500 /\n        SAR339658 o Patient who has taken other investigational medications within 2 months or 5\n        half lives, (whichever is longer) prior to screening o Use of any biologics for the\n        treatment of UC in the previous 8 weeks before screening o Requirement for concomitant\n        treatment that could bias primary evaluation o Pregnant or breast-feeding women o Women of\n        childbearing potential not protected by highly effective contraceptive method of birth\n        control   o Patient with latent or active tuberculosis (TB)  o Any signs or symptoms\n        suggestive of active TB upon medical history or clinical examination o Patients with a\n        positive QuantiFERON TB Gold Test o Chest radiograph within 3 months prior to the\n        inclusion visit consistent with prior tuberculosis infection including, but not limited\n        to, apical scarring, apical fibrosis, or multiple calcified granulomasa.  This does not\n        include non-caseating granulomasa o Patients with close contact with a person with active\n        tuberculosis o Patient with a history of listeriosis or tuberculosis (unless it is\n        documented that they were adequately treated)  o Administration of any live (attenuated)\n        vaccine within 3 months prior to the screening Visit (eg, varicella-zoster vaccine, oral\n        polio, rabies) o Positive Hepatitis B surface antigen (HBsAg) or positive Hepatitis B core\n        antibody (HBcAb); and/or positive Hepatitis C antibody (HCV) at the Screening Visit o\n        Prior opportunistic infections within six months prior to screening or while receiving\n        anti-TNF treatment o History of a hypersensitivity reaction, other than localized\n        injection site reaction (ISR), to any biological molecule o History or any current signs\n        of demyelinating disease or any neurological disease that can by the opinion of\n        Investigator interfere with study safety assessments including assessment for PML o\n        Patients with bleeding disorders or known platelet dysfunction   The above information is\n        not intended to contain all considerations relevant to a patient's potential participation\n        in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "93", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659138", 
            "org_study_id": "ACT12688", 
            "secondary_id": [
                "2012-002013-19", 
                "U1111-1124-1076"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "SAR339658", 
                "description": "Pharmaceutical form:solution Route of administration: intravenous", 
                "intervention_name": "SAR339658", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Pharmaceutical form:solution Route of administration: intravenous", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85012"
                    }, 
                    "name": "Investigational Site Number 840057"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sun City", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85351"
                    }, 
                    "name": "Investigational Site Number 840065"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90067"
                    }, 
                    "name": "Investigational Site Number 840031"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mission Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91345"
                    }, 
                    "name": "Investigational Site Number 840059"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92114"
                    }, 
                    "name": "Investigational Site Number 840074"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Littleton", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80120"
                    }, 
                    "name": "Investigational Site Number 840061"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maitland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32751"
                    }, 
                    "name": "Investigational Site Number 840041"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Investigational Site Number 840003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miramar,", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33025"
                    }, 
                    "name": "Investigational Site Number 840008"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34102"
                    }, 
                    "name": "Investigational Site Number 840044"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winter Park,", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32789"
                    }, 
                    "name": "Investigational Site Number 840048"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Savannah,", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "31405"
                    }, 
                    "name": "Investigational Site Number 840053"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "Investigational Site Number 840001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oak Lawn", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60453"
                    }, 
                    "name": "Investigational Site Number 840005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hammond", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70403"
                    }, 
                    "name": "Investigational Site Number 840078"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester Hills", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48098"
                    }, 
                    "name": "Investigational Site Number 840070"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ocean Springs", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39564"
                    }, 
                    "name": "Investigational Site Number 840060"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65265"
                    }, 
                    "name": "Investigational Site Number 840024"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Teaneck", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07666"
                    }, 
                    "name": "Investigational Site Number 840080"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11021"
                    }, 
                    "name": "Investigational Site Number 840051"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Investigational Site Number 840071"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville,", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28546"
                    }, 
                    "name": "Investigational Site Number 840018"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157-1071"
                    }, 
                    "name": "Investigational Site Number 840089"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45219"
                    }, 
                    "name": "Investigational Site Number 840046"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenixville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19460"
                    }, 
                    "name": "Investigational Site Number 840045"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15212"
                    }, 
                    "name": "Investigational Site Number 840090"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29203"
                    }, 
                    "name": "Investigational Site Number 840052"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Laredo", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78041"
                    }, 
                    "name": "Investigational Site Number 840082"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasadena,", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77505"
                    }, 
                    "name": "Investigational Site Number 840019"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Investigational Site Number 840088"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sugar Land", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77479"
                    }, 
                    "name": "Investigational Site Number 840038"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22908"
                    }, 
                    "name": "Investigational Site Number 840068"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298"
                    }, 
                    "name": "Investigational Site Number 840079"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98104-2499"
                    }, 
                    "name": "Investigational Site Number 840034"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wauwatosa", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Investigational Site Number 840064"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria", 
                        "zip": "6020"
                    }, 
                    "name": "Investigational Site Number 040003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "Austria", 
                        "zip": "1090"
                    }, 
                    "name": "Investigational Site Number 040001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "9000"
                    }, 
                    "name": "Investigational Site Number 056002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herentals", 
                        "country": "Belgium", 
                        "zip": "2200"
                    }, 
                    "name": "Investigational Site Number 056001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "zip": "N6A 5A5"
                    }, 
                    "name": "Investigational Site Number 124003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "zip": "K1H 1A2"
                    }, 
                    "name": "Investigational Site Number 124005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saskatoon", 
                        "country": "Canada", 
                        "zip": "S7N 0W8"
                    }, 
                    "name": "Investigational Site Number 124006"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "zip": "V6Z 2K5"
                    }, 
                    "name": "Investigational Site Number 124002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amiens Cedex 1", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Investigational Site Number 250002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "Investigational Site Number 250003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Roche Sur Yon Cedex 9", 
                        "country": "France", 
                        "zip": "85925"
                    }, 
                    "name": "Investigational Site Number 250005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "zip": "33600"
                    }, 
                    "name": "Investigational Site Number 250001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51092"
                    }, 
                    "name": "Investigational Site Number 250004"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre Les Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Investigational Site Number 250006"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Investigational Site Number 276009"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "14163"
                    }, 
                    "name": "Investigational Site Number 276001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Investigational Site Number 276004"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Investigational Site Number 276005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20246"
                    }, 
                    "name": "Investigational Site Number 276007"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "24105"
                    }, 
                    "name": "Investigational Site Number 276010"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Neustadt", 
                        "country": "Germany", 
                        "zip": "67433"
                    }, 
                    "name": "Investigational Site Number 276002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50141"
                    }, 
                    "name": "Investigational Site Number 380003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20157"
                    }, 
                    "name": "Investigational Site Number 380001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00168"
                    }, 
                    "name": "Investigational Site Number 380002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Giovanni Rotondo", 
                        "country": "Italy", 
                        "zip": "71013"
                    }, 
                    "name": "Investigational Site Number 380006"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elblag", 
                        "country": "Poland", 
                        "zip": "82-300"
                    }, 
                    "name": "Investigational Site Number 616003"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gdynia", 
                        "country": "Poland", 
                        "zip": "81-969"
                    }, 
                    "name": "Investigational Site Number 616001"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "90-242"
                    }, 
                    "name": "Investigational Site Number 616004"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "90302"
                    }, 
                    "name": "Investigational Site Number 616002"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "90-302"
                    }, 
                    "name": "Investigational Site Number 616005"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poznan", 
                        "country": "Poland", 
                        "zip": "60539"
                    }, 
                    "name": "Investigational Site Number 616007"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sroda Wielkopolska", 
                        "country": "Poland", 
                        "zip": "63-000"
                    }, 
                    "name": "Investigational Site Number 616006"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland", 
                        "zip": "03-580"
                    }, 
                    "name": "Investigational Site Number 616008"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Austria", 
                "Belgium", 
                "Canada", 
                "France", 
                "Germany", 
                "Italy", 
                "Poland"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)", 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of Participants with Clinical Response by Mayo Score", 
            "safety_issue": "No", 
            "time_frame": "At Week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659138"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of Participants with Clinical Remission by Mayo Score", 
                "safety_issue": "No", 
                "time_frame": "At Week 8"
            }, 
            {
                "measure": "Proportion of Participants with Mucosal Healing", 
                "safety_issue": "No", 
                "time_frame": "At Week 8"
            }, 
            {
                "measure": "Change from Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ)", 
                "safety_issue": "No", 
                "time_frame": "At Weeks 4 and 8"
            }, 
            {
                "measure": "Change from Baseline in Quality of Life (QoL) SF-36", 
                "safety_issue": "No", 
                "time_frame": "At Weeks 4 and 8"
            }, 
            {
                "measure": "Change from Baseline in the partial Mayo Score", 
                "safety_issue": "No", 
                "time_frame": "At Weeks 4 and 6"
            }, 
            {
                "measure": "Number of Participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to Week 17"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}